mRNA-based Shingles Vaccine: Pfizer and BioNTech to collaborate on development
by Press Release from Outbreak News Today on (#5TPWQ)
NewsDesk @infectiousdiseasenews Pfizer Inc. and BioNTech SE today announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), a debilitating, disfiguring and painful disease that impacts about one in three people in the United States during their lifetime. Under the terms [...]
The post mRNA-based Shingles Vaccine: Pfizer and BioNTech to collaborate on development appeared first on Outbreak News Today.